Type 2 diabetes: genotype-based therapy.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 25298318.
- Also identified by DOI 10.1126/scitranslmed.3010687.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Targeting a genetic variant with an antagonist may restore insulin secretion in a subgroup of type 2 diabetes patients (Tang et al., this issue).
Medical subject headings
- Adrenergic alpha-2 Receptor Antagonists
- Diabetes Mellitus, Type 2
- Receptors, Adrenergic, alpha-2